Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vitamin K and fractures

This article was originally published in The Tan Sheet

Executive Summary

Oral supplementation with vitamin K (phytonadione and menaquinone), especially vitamin K2 (menaquinone-4), is linked to increased bone mineral density and reduced fractures, according to a systematic review and meta-analysis published in the Archives of Internal Medicine June 26. The meta-analysis assess data from seven randomized controlled trials and found a "striking" 80% reduction in hip fractures with vitamin K supplementation, Sarah Cockayne, University of York, England, et al., state. "Our findings should be treated cautiously, however, because the studies were not primarily designed to show a fracture effect," they explain. The results of the meta-analysis and review suggest that people susceptible to fracture should eat a diet that is rich in vitamin K, "which is chiefly obtained from green leafy vegetables and certain vegetable oils," the study authors say...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099528

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel